MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM, Putranto EW, Kondo E, Murata H, Watanabe M, Huang P, Kinoshita R, Futami J, Inoue Y, Yamauchi A, Sumardika IW, Youyi C, Yamamoto K, Nasu Y, Nishibori M, Hibino T, Sakaguchi M.
Ruma IM, et al.
Clin Exp Metastasis. 2016 Aug;33(6):609-27. doi: 10.1007/s10585-016-9801-2. Epub 2016 May 5.
Clin Exp Metastasis. 2016.
PMID: 27151304